Joseph, S.C.; Eugin Simon, S.; Bohm, M.S.; Kim, M.; Pye, M.E.; Simmons, B.W.; Graves, D.G.; Thomas-Gooch, S.M.; Tanveer, U.A.; Holt, J.R.;
et al. FXR Agonism with Bile Acid Mimetic Reduces Pre-Clinical Triple-Negative Breast Cancer Burden. Cancers 2024, 16, 1368.
https://doi.org/10.3390/cancers16071368
AMA Style
Joseph SC, Eugin Simon S, Bohm MS, Kim M, Pye ME, Simmons BW, Graves DG, Thomas-Gooch SM, Tanveer UA, Holt JR,
et al. FXR Agonism with Bile Acid Mimetic Reduces Pre-Clinical Triple-Negative Breast Cancer Burden. Cancers. 2024; 16(7):1368.
https://doi.org/10.3390/cancers16071368
Chicago/Turabian Style
Joseph, Sydney C., Samson Eugin Simon, Margaret S. Bohm, Minjeong Kim, Madeline E. Pye, Boston W. Simmons, Dillon G. Graves, Stacey M. Thomas-Gooch, Ubaid A. Tanveer, Jeremiah R. Holt,
and et al. 2024. "FXR Agonism with Bile Acid Mimetic Reduces Pre-Clinical Triple-Negative Breast Cancer Burden" Cancers 16, no. 7: 1368.
https://doi.org/10.3390/cancers16071368
APA Style
Joseph, S. C., Eugin Simon, S., Bohm, M. S., Kim, M., Pye, M. E., Simmons, B. W., Graves, D. G., Thomas-Gooch, S. M., Tanveer, U. A., Holt, J. R., Ponnusamy, S., Sipe, L. M., Hayes, D. N., Cook, K. L., Narayanan, R., Pierre, J. F., & Makowski, L.
(2024). FXR Agonism with Bile Acid Mimetic Reduces Pre-Clinical Triple-Negative Breast Cancer Burden. Cancers, 16(7), 1368.
https://doi.org/10.3390/cancers16071368